( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
779.94
975.78
717.02
938.06
Total Expenditure
810.81
1076.6
774.86
852.78
PBIDT (Excl OI)
-30.86
-100.82
-57.84
85.28
Other Income
32.36
11.76
15.52
10.22
Operating Profit
1.49
-89.05
-42.32
95.5
Interest
27.65
24.7
24.5
27.88
Exceptional Items
NA
NA
NA
NA
PBDT
-26.16
-113.76
-66.82
67.62
Depreciation
25.74
25.53
25.32
25.4
Profit Before Tax
-51.9
-139.29
-92.14
42.22
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-53.55
-140.84
-77.52
30.81
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-53.55
-140.84
-77.52
30.81
Minority Interest
NA
0.00
0.00
NA
Shares of Associates
17.4
-1.36
-19.12
-25.62
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-36.16
-142.2
-96.64
5.19
Equity Capital
92.04
92.04
92.04
92.04
Calculated EPS
-0.39
-1.54
-1.04
0.05
Calculated EPS (Annualised)
-1.57
-6.17
-4.19
0.22
No of Public Share Holdings
30236130
30236130
30236130
30236130
% of Public Share Holdings
32.85
32.85
32.85
32.85
PBIDTM% (Excl OI)
-3.95
-10.33
-8.06
9.09
PBIDTM%
0.19
-9.12
-5.90
10.18
PBDTM%
-3.35
-11.65
-9.31
7.20
PBTM%
-6.65
-14.27
-12.85
4.50
PATM%
-6.86
-14.43
-10.81
3.28